SCHEMBL4664039

SCHEMBL4664039

Cc1cnc(CCC(N)=O)o1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 1/20 0.41
CCNE2 O96020 1/20 0.39
CDK4 P11802 1/20 0.39
CCND1 P24385 1/20 0.39
CCNE1 P24864 1/20 0.39
CDK2 P24941 1/20 0.39
RXRA P19793 3/20 0.39
RXRB P28702 2/20 0.39
RXRG P48443 2/20 0.39
FAAH O00519 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TP53 P04637 1/20 0.38
RAB9A P51151 1/20 0.38
KLF5 Q13887 1/20 0.38
MTNR1B P49286 1/20 0.35
NAMPT P43490 1/20 0.33
CAPN1 P07384 1/20 0.33
NR1H4 Q96RI1 1/20 0.32
HDAC3 O15379 3/20 0.31
HDAC4 P56524 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4632525 0.84 RXRA (0.54) NR4A2CCNE2CDK4CCND1CCNE1
SCHEMBL22723848 0.81 CCNE1 (0.40) CCNE2CDK4CCND1CCNE1CDK2
Acetic Acid SCHEMBL31591118 0.75 CCNE2 (0.42) CCNE2CDK4CCND1CCNE1CDK2
SCHEMBL12128445 0.72
SCHEMBL50579 0.72 CCNE2 (0.46) CCNE2CDK4CCND1CCNE1CDK2
SCHEMBL22352802 0.72 HDAC1 (0.45) CCNE2CDK4CCND1CCNE1CDK2
SCHEMBL22015494 0.72 CCNE1 (0.44) CCNE2CDK4CCND1CCNE1CDK2
SCHEMBL5672243 0.72 MTNR1B (0.37) CCNE2CDK4CCND1CCNE1CDK2
SCHEMBL18606443 0.72 CCNE2 (0.41) NR4A2CCNE2CDK4CCND1CCNE1
SCHEMBL4164113 0.72 MTNR1B (0.37) CCNE2CDK4CCND1CCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2007717-A1 NOVEL SULFONAMIDE COMPOUNDS Actelion Pharmaceuticals Ltd. (CH) 2008-12-31 EP claimed
WO-2007116374-A1 NOVEL SULFONAMIDE COMPOUNDS ACTELION PHARMACEUTICALS LTD (CH) 2007-10-18 WO claimed
US-7528140-B2 Substituted pyrrolo[3,2-d]pyrimidines as glycogen synthase kinase (GSK) inhibitors TEIJIN LIMITED (JP) 2009-05-05 US disclosed
US-7528140-B2 Substituted pyrrolo[3,2-d]pyrimidines as glycogen synthase kinase (GSK) inhibitors TEIJIN LIMITED (JP) 2009-05-05 US disclosed